Company intelligence / Profile preview

Zolfo Cooper

New York, New York, USA

Ownership: Private
Development stage: Other

Overview

Zolfo Cooper was a leading global financial advisory and restructuring firm specializing in turnaround management, corporate recovery, and insolvency services. Although not a biotechnology or life sciences company by core business, the firm played a significant role in the healthcare sector by advising distressed hospitals, pharmaceutical manufacturers, and medical device companies through complex financial reorganizations. The firm gained international prominence for its leadership in high-profile bankruptcy cases and corporate transformations across various industries. Between 2015 and 2020, Zolfo Cooper's various regional practices were acquired by AlixPartners and McKinsey & Company. Today, its legacy and expertise continue through the integrated service offerings of its acquirers.

Industry: Consulting

Beyond the preview

Go deeper on Zolfo Cooper.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zolfo Cooper.

Explore the full profile